A Double-Blind, Placebo-Controlled, Randomized Phase II Pilot Study to Investigate the Potential Efficacy of the Traditional Chinese Medicine Neuroaid (MLC 601) in Enhancing Recovery after Stroke (TIERS)

Publisher： Karger

E-ISSN： 1421-9786|28|5|514-521

ISSN： 1015-9770

Source： Cerebrovascular Diseases, Vol.28, Iss.5, 2009-10, pp. : 514-521

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and Safety of MLC601 in the Treatment of Mild Cognitive Impairment: A Pilot, Randomized, Double-Blind, Placebo-Controlled Study


By  

Dementia and Geriatric Cognitive Disorders Extra, Vol. 7, Iss. 1, 2017-05 ,pp. : 136-142

Karger

Access to resources Recommend Favorite

Safety Profile of MLC601 (Neuroaid®) in Acute Ischemic Stroke Patients: A Singaporean Substudy of the Chinese Medicine Neuroaid Efficacy on Stroke Recovery Study

By  

Cerebrovascular Diseases, Vol. 30, Iss. 1, 2010-04 ,pp. : 1-6

Karger

Access to resources Recommend Favorite

Efficacy and Safety of MLC601 (NeuroAiD®), a Traditional Chinese Medicine, in Poststroke Recovery: A Systematic Review

By  

Cerebrovascular Diseases, Vol. 35, Iss. 1, 2013-03 ,pp. : 8-17

Karger

Access to resources Recommend Favorite

Prognostic Factors and Pattern of Long-Term Recovery with MLC601 (NeuroAiD™) in the Chinese Medicine NeuroAiD Efficacy on Stroke Recovery - Extension Study

By  

Cerebrovascular Diseases, Vol. 43, Iss. 1-2, 2016-11 ,pp. : 36-42

Karger

Access to resources Recommend Favorite

A Double-Blind Placebo-Controlled Study of the Effects of Amphetamine and Physiotherapy after Stroke

By  

Cerebrovascular Diseases, Vol. 12, Iss. 3, 2001-10 ,pp. : 253-257

Karger

Access to resources Recommend Favorite